CHEK1 and Miyoshi myopathy: In this manuscript, we identified that concomitant overexpression of CHK1 and WEE1 is associated with a poor outcome in MM including newly diagnosed MM patients treated by high dose melphalan and ASCT and patients at relapse treated with anti-CD38 MoAb.